NIH: National Institutes of Health
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics


NIDA Home > Publications > NIDA Notes > Information   

NIDA Notes Information
gray line



NIDA Notes covers drug abuse research in the areas of treatment and prevention, epidemiology, neuroscience, behavioral science, health services, and AIDS. The publication reports on research; identifies resources; and promotes communication among clinicians, researchers, administrators, policymakers, and the public. Readers are encouraged to identify subject areas they would like to see highlighted.

NIDA Notes is a publication of the U.S. Government produced by the National Institute on Drug Abuse. Use of funds for printing this periodical has been approved by the Director of the Office of Management and Budget. Except for material specifically identified as copyrighted, all materials appearing in NIDA Notes are in the public domain and may be reproduced without permission. Citation of the source is appreciated.

 

Editor: David Anderson, Public Health Advisor, Public Information and Liaison Branch, Office of Science Policy and Communications, National Institute on Drug Abuse

Managing Editor: Simon Weavers, MasiMax Resources, Inc.

Editorial Board: David Anderson, Chair; Public Health Advisor, Public Information and Liaison Branch, Office of Science Policy and Communications

Jessica Campbell Chambers, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research

J.C. Comolli, Public Health Advisor, Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Gaya Dowling, Ph.D., Deputy Branch Chief, Science Policy Branch, Office of Science Policy and Communications

Lynda Erinoff, Ph.D., Associate Director, AIDS Research Program, Division of Epidemiology, Services and Prevention Research

Marsha F. Lopez, Ph.D., Health Scientist Administrator, Division of Epidemiology, Services and Prevention Research

Gerald McLaughlin, Ph.D., Chief, Grants Review Branch, Office of Extramural Affairs

Mary Ellen Michel, Ph.D., Deputy Director, Center for the Clinical Trials Network

Ivan Montoya, M.D., M.P.H., Medical Officer, Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Joni Rutter, Ph.D., Program Director, Genetics and Molecular Neurobiology Research Branch, Division of Basic Neuroscience and Behavioral Research

Vincent Smeriglio, Ph.D., Research Psychologist, Division of Clinical Neuroscience, Development and Behavioral Treatment

Frank Vocci, Ph.D., Director, Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Cora Lee Wetherington, Ph.D., Psychologist, Behavioral and Cognitive Science Research Branch, Division of Basic Neuroscience and Behavioral Research

Staff Writers: Elizabeth Ashton, and Lori Whitten, Ph.D., MasiMax Resources, Inc.

Contributing Writer: Carl Sherman

Senior Editor: Debra Davis, MasiMax Resources, Inc.

Design/Layout: Maggie Bray, MasiMax Resources, Inc.

This publication was produced and printed by MasiMax Resources, Inc., under Contract No. N01DA-4-1117 from the National Institute on Drug Abuse.

 


About NIDA Notes

Free Subscription
to NIDA Notes

Volumes:

For additional information about NIDA Notes, send e-mail to Information@nida.nih.gov



NIDA Home | Site Map | Search | FAQs | Accessibility | Help | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, March 17, 2008. The U.S. government's official web portal